Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema

Overview of attention for article published in Cochrane database of systematic reviews, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

blogs: 1 blog
twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 183 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 1 users.

Cochrane Airways, 30 Oct 2019

Intrapleural fibrinolytics may increase the rate of serious adverse events, but the evidence is insufficient to confirm or…

Cochrane Airways, 30 Oct 2019

New #CochraneEvidence: Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.